Clinical trial IJB_2674
A Phase 2, Open-Label, Single-Arm, Multicenter Study to Evaluate the Efficacy and Safety of INCB054828 in Subjects With Advanced/Metastatic or Surgically Unresectable Cholangiocarcinoma Including FGFR2 Translocations Who Failed Previous Therapy
| Cancers | |
|---|---|
| Organ | Liver |
| Trial status | Trial closed |
| Trial type |
Interventional with experimental drug
|
| Phase | Trial phase 2 |
| Academic trial | Non |
| Sponsor | Incyte Corporate |
| EudraCT Identifier | 2016-002422-36 |
| ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT02924376 |
| Inclusion criteria | second line metastatic |
| Last update |